The results of the first survey to be conducted in Central America using the IOF calcium calculator have been published.
We’re so very proud of the members of IOF’s Committee of Scientific Advisors (CSA). The CSA members, elected to the Committee by their peers, are recognized as leading global experts ...
Experts from the International Osteoporosis Foundation have developed a 15-question survey with the aim of assessing international perspectives and experience on the management of rare phosphate-related conditions known as hypophosphatemic ...
Bone turnover markers have been widely utilised in the field of osteoporosis, particularly for the purpose of monitoring treatment adherence. However, a thorough understanding of the use and interpretation of ...
The International Osteoporosis Foundation (IOF) Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria. The multinational ...
Osteoporosis predominantly affects postmenopausal women and older men. However, although far more rarely, it can also occur in younger individuals affected by certain conditions and disorders.
Calcified Tissue International and ...
The HIPGEN study includes a network of 10 partners from eight countries, as well as the International Osteoporosis Foundation (IOF) as a communications partner. It is a Phase III, multicenter ...
Fragility fractures, which affect an estimated one in three women and one in five men over the age of 50 years worldwide, are a major cause of disability and loss ...
Osteoporosis is a major health care burden in Europe which results in 4.3 million fragility fractures and health care costs in excess of €56 billion annually.
Presenting impactful data for ...
In achieving its enrolment target in November 2021, an important milestone has been reached by the Phase III PLX-PAD study.
HIPGEN - Cell Therapy for Improving Patient Mobility after Hip Fracture ...
Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could share pathophysiological mechanisms.
A ...
‘The Hipgen Trial - Cell Therapy for Improving Patient Mobility after Hip Fracture Arthroplasty’, is among the many topical symposia scheduled at the upcoming virtual World Congress on ...